Delivery Order SPE2DX22D0010-SPE2D825FJC02

This delivery order, valued at $3,270.81, was awarded on September 3, 2025, to AmerisourceBergen Drug Corp (CAGE 0U9U0) by the Defense Logistics Agency's Medical Supply Chain division under a firm fixed-price contract with a completion date of September 4, 2025. The award represents a child contract—a specific task order issued under a larger indefinite delivery vehicle. AmerisourceBergen maintains a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX) through December 2026, which serves as the parent contract vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order was awarded competitively with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of medical commodities, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare products across multiple therapeutic domains. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving defense healthcare customers alongside the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles.